Melatonin supplementation may be associated with ventricular arrhythmia in some individuals
A 63-year-old man developed ventricular arrhythmia while taking 10 mg of exogenous melatonin daily, with complete resolution of symptoms and improvement in electrocardiographic findings after discontinuation. A systematic review identified similar arrhythmic events associated with melatonin supplementation, with symptom resolution or clinical improvement after stopping the supplement.
Evidence Score
Study Evidence
Study 1. Atrioventricular Block Potentially Associated with Melatonin Supplementation: A Case Report and Systematic Review of Cardiac Rhythm Adverse Events.
observationalSola E, Ramos E, Romero A, Monzón D ยท Pharmaceuticals (Basel, Switzerland) (2026)
Result:
Mechanism Graph
Limitations
- โ Single case report with limited generalizability
- โ Systematic review may include heterogeneous and low-quality reports
Frequently Asked Questions
What dose of melatonin was associated with the arrhythmia?โผ
The patient was taking 10 mg of exogenous melatonin daily.
Did the patient recover after stopping melatonin?โผ
Yes, the patient experienced complete resolution of symptoms and improvement in electrocardiographic findings after discontinuing melatonin.
Is melatonin generally safe for the heart?โผ
Melatonin is generally regarded as safe with cardioprotective effects, but this report and systematic review suggest rare cardiac rhythm adverse events may occur.
What mechanisms might explain melatonin-related arrhythmias?โผ
Possible mechanisms include melatonin receptor effects, sleep architecture changes, pharmacokinetic variability, and genetic predisposition.
Products
Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.
References
- 1.Sola E, Ramos E, Romero A, Monzón D. "Atrioventricular Block Potentially Associated with Melatonin Supplementation: A Case Report and Systematic Review of Cardiac Rhythm Adverse Events.." Pharmaceuticals (Basel, Switzerland), 2026. PMID: 42515750 DOI: 10.3390/ph19071069